Method for enhancing the effectiveness of cancer therapies

Details for Australian Patent Application No. 2002320140 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 10/176,235 20.06.02 US; 60/299,991 21.06.01 US

19 June 2003 Application Open to Public Inspection

Published as AU-B-2002320140

29 November 2007 Application Accepted

Published as AU-B-2002320140

24 January 2008 Amendment Made

The nature of the amendment is: Amend co-inventor names from Chang, Yang to Chang, Yan and Sasek, Vodek to Sasak, Vodek

31 January 2008 Assignment before Grant

Glycogenesys, Inc. The application has been assigned to Prospect Therapeutics, Inc.

3 April 2008 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.